For the Inventor, By the Inventor

Enter assignee name

Hellerup, Denmark

Ascendis Pharma A/s

USPTO Granted Patents = 44

CIPO Patents = 76

EPO Patents = 26

Trademarks = 9

Forward Citations = 396

Loading Chart...

Loading Chart...

145 inventors (with patents filed for the assignee):

Harald Rau (25 out of 56 patents)

Ulrich Hersel (16 out of 40 patents)

Steen Jensen (11 out of 11 patents)

4. Henrik Egesborg (11 out of 13 patents)

5. Thomas Wegge (10 out of 38 patents)

6. Per Mølgaard Pedersen (9 out of 9 patents)

7. Nicola Bisek (9 out of 10 patents)

8. Jan Olesen (8 out of 22 patents)

9. Flemming Madsen (8 out of 14 patents)

10. Dirk Vetter (6 out of 21 patents)

11. Thomas Knappe (6 out of 7 patents)

12. Tobias Voigt (6 out of 7 patents)

13. Kennett Sprogøe (5 out of 28 patents)

14. Samuel Weisbrod (5 out of 6 patents)

15. Guillaume Maitro (5 out of 13 patents)

44 patents: Sort by Forward Citations

1. D1090824 - Injector with cover (2025-08-26),

2. 12383676 - Auto injector with charger safety (2025-08-12),

3. 12296148 - Auto injector with temperature control (2025-05-13),

4. 12290663 - Front loaded auto injector for administering a medicament (2025-05-06),

5. 12251541 - Auto injector with variable plunger force (2025-03-18),

6. 12246070 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods (2025-03-11),

7. 12226616 - Auto injector with adaptable air-shot mechanism (2025-02-18),

8. 12005241 - Auto injector with detection of used cartridge and associated method (2024-06-11),

9. 11969581 - Auto injector with adaptable air-shot mechanism (2024-04-30),

10. 11896671 - Conjugation method for carrier-linked prodrugs (2024-02-13),

11. 11738147 - Auto injector with charger safety (2023-08-29),

12. 11684724 - Auto injector with variable plunger force (2023-06-27),

13. 11642415 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods (2023-05-09),

14. 11633487 - Prodrugs comprising an aminoalkyl glycine linker (2023-04-25),

15. 11607496 - Front loaded auto injector for administering a medicament (2023-03-21),

Ascendis Pharma A/S is a biopharmaceutical company that develops innovative therapies for patients with rare endocrine diseases. Their unique TransCon technology platform allows for the sustained release of therapeutic proteins, providing patients with improved treatment options. They are dedicated to improving the lives of patients and exploring the potential in endocrinology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

44 Patents

#1 in Hellerup

#71 in Denmark

#15,270 in the World

Hellerup, Denmark

Ascendis Pharma A/s

Forward Citations = 396

145 inventors:

Harald Rau (25 out of 56 patents)

Ulrich Hersel (16 out of 40 patents)

Steen Jensen (11 out of 11 patents)

4. Henrik Egesborg (11 out of 13 patents)

5. Thomas Wegge (10 out of 38 patents)

Please report any incorrect information to support@idiyas.com

Loading…